Organisation paid for research Program year 2023 Source: CMS Open Payments

Alkek Eye Center

Neither a doctor nor a teaching hospital

Research payments

$72,377

2 payments

Through program year 2023, Alkek Eye Center is reported as receiving $72,377 in research payments, across 2 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2023	Research	$9,450	1
2022	Research	$62,927	1

Breakdown

Who paid Research payments · program years 2022–2023

Novartis Pharmaceuticals Corporation $72,377 2 payments

Studies the money was for Research payments · program years 2022–2023

A 12-Week Parallel Group, Randomized, Placebo-Controlled, Double-Blinded, Multi-Center Study to Evaluate Efficacy and Safety of 2 Concentrations of Saf312 Eye Drops (5 MG/ML and 15 MG/ML) Used Twice-Daily in the Treatment of Post-Operative Corneal Induced $62,927 1 payment
A 12-Week Parallel Group, Randomized, Placebo-Controlled, Double-Blinded, Multi-Center Study to Evaluate Efficacy and Safety of 2 Concentrations of Saf312 Eye Drops (5 MG/ML and 15 MG/ML) Used Twice-Daily in the Treatment of Post-Operative Corneal Induced Chronic Pain (Cicp) Following Photorefractive Keratectomy (PRK) Or Laser-Assisted in Situ Keratomileusis (Lasik) Surgeries $9,450 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.